Table 2.
β-blockers inhibit tumorigenesis in cell and animal models.
| Drug name | Effect in tumor models or cell lines | Tumor types and references |
|---|---|---|
| Propranolol | Inhibition of growth and proliferation | Pancreatic ductal adenocarcinoma (89), breast cancer (90, 91), neuroblastoma (92), angiosarcoma (55, 93), melanoma (94–97), pancreatic cancer cells (98), gastric cancer cells (99, 100), neuroblastoma cells (92), hemangioendothelioma cells (93), angiosarcoma cells (55, 93), colorectal cancer cells (101), melanoma cells (94, 96), breast cancer cells (102), liver cancer cells (103), prostate cancer cells (104) |
| Inhibition of migration | Colon carcinoma cells (105), breast cancer cells (106) | |
| Inhibition of invasion | Ovarian cancer cells (107), pancreatic cancer cells (108) | |
| Inhibition of metastasis | Prostate cancer (109), melanoma (95) | |
| Prolonged survival of tumor-bearing animals | Neuroblastoma (92) | |
| Carvedilol | Inhibition of growth and proliferation | Neuroblastoma and neuroblastoma cells (92) |
| Nebivolol | Inhibition of growth and proliferation | Neuroblastoma and neuroblastoma cells (92) |